Gainers

 


  • eFFECTOR Therapeutics EFTR stock rose 4.43% to $17.91 during Friday's after-market session. The market value of their outstanding shares is at $728.3 million.

  • Burning Rock Biotech BNR stock rose 4.42% to $19.57. The market value of their outstanding shares is at $2.0 billion.

  • Conformis CFMS stock rose 3.81% to $1.36. The market value of their outstanding shares is at $252.9 million.

  • Esperion Therapeutics ESPR stock moved upwards by 3.1% to $11.94. This security traded at a volume of 63.5K shares come close, making up 8.84% of its average volume over the last 100 days. The market value of their outstanding shares is at $337.6 million.

  • NRX Pharmaceuticals NRXP shares moved upwards by 2.97% to $9.7. The company's market cap stands at $521.6 million.

  • OpGen OPGN stock increased by 2.62% to $3.13. The company's market cap stands at $119.7 million.


  •  

 

 

Losers

 

 


  • Immuron IMRN stock decreased by 7.7% to $4.2 during Friday's after-market session. The market value of their outstanding shares is at $23.8 million.

  • OPKO Health OPK shares fell 5.6% to $3.54. At the close, OPKO Health's trading volume reached 164.6K shares. This is 4.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.4 billion.

  • Protagenic Therapeutics PTIX stock fell 3.39% to $2.0. The company's market cap stands at $33.5 million.

  • Unicycive Therapeutics UNCY stock declined by 3.14% to $2.78. The market value of their outstanding shares is at $40.3 million.

  • Sio Gene Therapies SIOX shares fell 2.95% to $2.31. The market value of their outstanding shares is at $168.4 million.

  • electroCore ECOR shares decreased by 2.59% to $1.13. The market value of their outstanding shares is at $78.5 million.
    See Also: www.benzinga.com/money/best-healthcare-stocks/


  •  

 

 

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!